Intervention: Subcutaneous administration of recombinant human IGF-1
Found 7 matching trials
Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1
PHASE2
To investigate the effects of rhIGF-I/rhIGFBP-3 treatment for 24 weeks on e...
Status
Completed
Location
University of California Irvine Medical Center; MDA, ALS and Neuromuscular Center